Top

Health and Quality of Life Outcomes

Published in:

Open Access 01-12-2021 | Research

Assessing the reliability and validity of the ICECAP-A instrument in Chinese type 2 diabetes patients

Authors: Yao Xiong, Hongyan Wu, Judy Xu

Published in: Health and Quality of Life Outcomes | Issue 1/2021

Abstract

Purpose

We aimed to conduct psychometric tests for the Chinese version of ICECAP-A and compare the differences between ICECAP-A and EQ-5D-3L for patients with T2DM and explore the relationship between clinical conditions and ICECAP-A through diabetes-related clinical indicators.

Methods

Data were collected from a sample of 492 Chinese T2DM patients. The reliability and validity of the ICECAP-A were verified. Exploratory factor analysis (EFA), correlation analysis and regression analysis were conducted for both the ICECAP-A and EQ-5D-3L.

Results

Our results show that the Chinese version of ICECAP-A has good internal consistency with an overall Cronbach’s Alpha coefficient of 0.721. The mean scores of ICECAP-A and EQ-5D-3L are 0.85 vs. 0.94. A weak correlation (r = 0.116) was found between the ICECAP-A tariff and EQ-5D-3L utility. EFA showed that although the five dimensions of the ICECAP-A and EQ-5D-3L scales were loaded into two different factors respectively. However, the two scales captured different dimensions of quality of life and can complement each other. The ICECAP-A, EQ-5D-3L, and EQ-VAS scores showed differences across different socio-demographic characteristics and clinic conditions groups.

Conclusion

The Chinese version of the ICECAP-A capability instrument can be for assessing outcomes in adults with T2DM. It may capture more dimensions of QoL than traditional Health-related QoL (HRQoL) instruments and may be useful for economic evaluations of health care and social care for people with T2DM or other chronic diseases.

Available only for authorised users

CDMS is conducted by the Center of Health Policy and Governance (CHPG) at Southwestern University of Finance and Economics (SWUFE) with funding support from National Nature Science foundation of China (NSFC) and Sichuan Education Department Fund for Innovative Teams. The protocol was approved by the institutional review board and all participants.

Wang L, Gao P, Zhang M, Huang Z, Zhang D, Deng Q, et al. Prevalence and ethnic pattern of diabetes and Prediabetes in China in 2013. JAMA. 2017;317(24):2515–23. https://doi.org/10.1001/jama.2017.7596.CrossRefPubMedPubMedCentral

IDF. IDF DIABETES ATLAS 9th edition 2019. International Diabetes Federation. International Diabetes Federation. 2019. Available at: https://diabetesatlas.org/data/en. Accessed May 9 2020.

Foos V, Wang K, McEwan P, Zhang Y, Xin P, Jiang X, et al. Assessing the burden of type 2 diabetes in China considering the current status-quo management and implications of improved management using a modeling approach. Value Health Reg Issues. 2019;18:36–46. https://doi.org/10.1016/j.vhri.2018.08.006.CrossRefPubMed

Zhou T, Guan H, Yao J, Xiong X, Ma A. The quality of life in Chinese population with chronic non-communicable diseases according to EQ-5D-3L: a systematic review. Qual Life Res. 2018;27(11):2799–814. https://doi.org/10.1007/s11136-018-1928-y.CrossRefPubMedPubMedCentral

Janssen MF, Lubetkin EI, Sekhobo JP, Pickard AS. The use of the EQ-5D preference-based health status measure in adults with type 2 diabetes mellitus. Diabet Med. 2011;28(4):395–413. https://doi.org/10.1111/j.1464-5491.2010.03136.x.CrossRefPubMed

Mitchell PM, Al-Janabi H, Byford S, Kuyken W, Richardson J, Iezzi A, et al. Assessing the validity of the ICECAP-A capability measure for adults with depression. BMC Psychiatry. 2017;17(1):46. https://doi.org/10.1186/s12888-017-1211-8.CrossRefPubMedPubMedCentral

Al-Janabi H, Keeley T, Mitchell P, Coast J. Can capabilities be self-reported? A think aloud study. Soc Sci Med. 2013;87:116–22. https://doi.org/10.1016/j.socscimed.2013.03.035.CrossRefPubMedPubMedCentral

Dang A-T. Amartya Sen's Capability approach: a framework for well-being evaluation and policy analysis? Rev Soc Econ. 2014;72(4):460–84. https://doi.org/10.1080/00346764.2014.958903.CrossRef

Tang C, Xiong Y, Wu H, Xu J. Adaptation and assessments of the Chinese version of the ICECAP-A measurement. Health Qual Life Outcomes. 2018;16(1):45. https://doi.org/10.1186/s12955-018-0865-3.CrossRefPubMedPubMedCentral

10.

Capability SA. Well-Being. In: Sen MCNA, editor. The quality of life. Oxford: Oxford University Press; 1993. p. 30–53.

11.

Al-Janabi H, Flynn TN, Coast J. Development of a self-report measure of capability wellbeing for adults: the ICECAP-A. Qual Life Res. 2012;21(1):167–76. https://doi.org/10.1007/s11136-011-9927-2.CrossRefPubMed

12.

Keeley T, Coast J, Nicholls E, Foster NE, Jowett S, Al-Janabi H. An analysis of the complementarity of ICECAP-A and EQ-5D-3 L in an adult population of patients with knee pain. Health Qual Life Outcomes. 2016;14:36. https://doi.org/10.1186/s12955-016-0430-x.CrossRefPubMedPubMedCentral

13.

Flynn TN, Huynh E, Peters TJ, Al-Janabi H, Clemens S, Moody A, et al. Scoring the Icecap-a Capability instrument. Estimation of a UK general population tariff. Health Econ. 2015;24(3):258–69. https://doi.org/10.1002/hec.3014.CrossRefPubMed

14.

Liu GG, Wu H, Li M, Gao C, Luo N. Chinese time trade-off values for EQ-5D health states. Value Health. 2014;17(5):597–604. https://doi.org/10.1016/j.jval.2014.05.007.CrossRefPubMed

15.

Keeley T, Al-Janabi H, Lorgelly P, Coast J. A qualitative assessment of the content validity of the ICECAP-A and EQ-5D-5L and their appropriateness for use in health research. PLoS One. 2013;8(12):e85287. https://doi.org/10.1371/journal.pone.0085287.CrossRefPubMedPubMedCentral

16.

Goranitis I, Coast J, Al-Janabi H, Latthe P, Roberts TE. The validity and responsiveness of the ICECAP-A capability-well-being measure in women with irritative lower urinary tract symptoms. Qual Life Res. 2016;25(8):2063–75. https://doi.org/10.1007/s11136-015-1225-y.CrossRefPubMedPubMedCentral

17.

Linton M-J, Mitchell PM, Al-Janabi H, Schlander M, Richardson J, Iezzi A, et al. Comparing the German translation of the ICECAP-A Capability wellbeing measure to the original English version: psychometric properties across healthy samples and seven health condition groups. Appl Res Qual Life. 2018;15(3):651–73. https://doi.org/10.1007/s11482-018-9681-5.CrossRef

18.

Shahtaheri RS, Nikfar S, Sari AA, Yekani Nejad MS. Cross-cultural adaptation and psychometric analysis of the Persian version of the ICEpop CAPability measure for adults Capability measure in the Iranian general population. Value Health Reg Issues. 2020;21:188–93. https://doi.org/10.1016/j.vhri.2020.01.001.CrossRefPubMed

19.

Williams B, Onsman A, Brown T. Exploratory factor analysis: a five-step guide for novices. Australasian J Paramed. 2010;8(3). https://doi.org/10.33151/ajp.8.3.93.

20.

Watkins MW. Exploratory factor analysis: a guide to best practice. J Black Psychol. 2018;44(3):219–46. https://doi.org/10.1177/0095798418771807.CrossRef

21.

Al-Janabi H, Peters TJ, Brazier J, Bryan S, Flynn TN, Clemens S, et al. An investigation of the construct validity of the ICECAP-A capability measure. Qual Life Res. 2012;22(7):1831–40. https://doi.org/10.1007/s11136-012-0293-5.CrossRefPubMedPubMedCentral

22.

Pan CW, Sun HP, Zhou HJ, Ma Q, Xu Y, Luo N, et al. Valuing health-related quality of life in type 2 diabetes patients in China. Med Decis Mak. 2016;36(2):234–41. https://doi.org/10.1177/0272989X15606903.CrossRef

23.

Carroll RJ, Ruppert D. Robust estimation in Heteroscedastic linear models. Ann Stat. 1982;10(2):429–41.CrossRef

24.

Yang F, Jiang S, He XN, Li HC, Wu HY, Zhang TT, et al. Do rural residents in China understand EQ-5D-5L as intended? Evidence from a qualitative study. Pharmacoecon Open. 2020. https://doi.org/10.1007/s41669-020-00212-z.

25.

Helter TM, Coast J, Laszewska A, Stamm T, Simon J. Capability instruments in economic evaluations of health-related interventions: a comparative review of the literature. Qual Life Res. 2020;29(6):1433–64. https://doi.org/10.1007/s11136-019-02393-5.CrossRefPubMed

26.

Badia X, Herdman M, Kind P. The influence of ill-health experience on the valuation of health. Pharmacoeconomics. 1998;13(6):687–96. https://doi.org/10.2165/00019053-199813060-00005.CrossRefPubMed

27.

Dolan P. The effect of experience of illness on health state valuations. J Clin Epidemiol. 1996;49(5):551–64. https://doi.org/10.1016/0895-4356(95)00532-3.CrossRefPubMed

28.

Souchek J, Byrne MM, Kelly PA, K OM, Richardson M, Pak C, et al. Valuation of arthritis health states across ethnic groups and between patients and community members. Med Care. 2005;43(9):921–8. https://doi.org/10.1097/01.mlr.0000173600.53788.13.CrossRefPubMed

29.

Wittenberg E, Halpern E, Divi N, Prosser LA, Araki SS, Weeks JC. The effect of age, race and gender on preference scores for hypothetical health states. Qual Life Res. 2006;15(4):645–53. https://doi.org/10.1007/s11136-005-3514-3.CrossRefPubMed

30.

Mitchell PM, Venkatapuram S, Richardson J, Iezzi A, Coast J. Are quality-adjusted life years a good proxy measure of individual capabilities? Pharmacoeconomics. 2017;35(6):637–46. https://doi.org/10.1007/s40273-017-0495-3.CrossRefPubMedPubMedCentral

31.

Al-Janabi H, Flynn TN, Peters TJ, Bryan S, Coast J. Test-retest reliability of capability measurement in the UK general population. Health Econ. 2015;24(5):625–30. https://doi.org/10.1002/hec.3100.CrossRefPubMed

32.

Holst-Kristensen AW, Fonager K, Pedersen KM. Test–retest reliability of ICECAP-A in the adult Danish population. Qual Life Res. 2019;29(2):547–57. https://doi.org/10.1007/s11136-019-02331-5.CrossRefPubMed

33.

Liu L, Li S, Wang M, Chen G. Comparison of EQ-5D-5L health state utilities using four country-specific tariffs on a breast cancer patient sample in mainland China. Patient Prefer Adherence. 2017;11:1049–56. https://doi.org/10.2147/PPA.S138028.CrossRefPubMedPubMedCentral

34.

Wu; H, Sun L. International comparison of methods for establishing the tariff of EQ-5D and the results. Chinese J New Drugs (in Chinese). 2012;21(6):581–97.

35.

Zhao Y, Li SP, Liu L, Zhang JL, Chen G. Does the choice of tariff matter?: a comparison of EQ-5D-5L utility scores using Chinese, UK, and Japanese tariffs on patients with psoriasis vulgaris in central South China. Medicine (Baltimore). 2017;96(34):e7840. https://doi.org/10.1097/MD.0000000000007840.CrossRef

36.

Bago d'Uva T, Van Doorslaer E, Lindeboom M, O'Donnell O. Does reporting heterogeneity bias the measurement of health disparities? Health Econ. 2008;17(3):351–75. https://doi.org/10.1002/hec.1269.CrossRefPubMed

37.

Correll SJ. Gender and the career choice process: the role of biased self-assessments. Am J Sociol. 2001;106(6):1691–730. https://doi.org/10.1086/321299.CrossRef

38.

Salomon JA, Tandon A, Murray CJ. Comparability of self rated health: cross sectional multi-country survey using anchoring vignettes. BMJ. 2004;328(7434):258. https://doi.org/10.1136/bmj.37963.691632.44.CrossRefPubMedPubMedCentral

Title: Assessing the reliability and validity of the ICECAP-A instrument in Chinese type 2 diabetes patients
Authors: Yao Xiong
Hongyan Wu
Judy Xu
Publication date: 01-12-2021
Publisher: BioMed Central
Published in: Health and Quality of Life Outcomes / Issue 1/2021
Electronic ISSN: 1477-7525
DOI: https://doi.org/10.1186/s12955-020-01632-5

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Assessing the reliability and validity of the ICECAP-A instrument in Chinese type 2 diabetes patients

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2021

Effects of social support, hope and resilience on depressive symptoms within 18 months after diagnosis of prostate cancer

Development and validity assessment of a Japanese version of the Exercise Adherence Rating Scale in participants with musculoskeletal disorders

Importance of personality and coping expectancy on patient-reported hearing disability, quality of life and distress level: a study of patients referred to an audiology service

Psychometric properties of the WHOQOL-BREF(PT) in a sample of elderly citizens

The prevalence and socio-behavioural and clinical covariates of oral health related quality of life in Ugandan mothers with and without HIV-1

Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L